Fisher Asset Management
MIRM icon

Fisher Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Fisher Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.66M Sell
82,476
-10,633
-11% -$1.07M ﹤0.01% 416
2026
Q1 		$8.6M Buy
93,109
+79,020
+561% +$7.43M ﹤0.01% 408
2025
Q4 		$1.11M Buy
+14,089
New +$1.01M ﹤0.01% 658

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management's MIRM Position: Q2 2026 in Review

Fisher Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, selling an estimated $1.07M and leaving 82,476 shares worth $9.66M. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Fisher Asset Management first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Fisher Asset Management held 82,476 shares of Mirum Pharmaceuticals worth $9.66M as of Q2 2026.
  • Fisher Asset Management sold 10,633 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #416 holding.
  • Fisher Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.